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Abstract
A 26-year-old man with a history of nasopharyngeal carcinoma 
(NPC) presented with bone metastasis. Bone scan revealed diffuse 
skeletal metastases with superscan appearance. Afterward, radio-
therapy for bone lesions was arranged and the effects were evalu-
ated. The bone scan flare phenomenon appeared within a short time 
after radiotherapy. Diffuse bone metastasis, which is common in 
NPC, were indeterminate on images showing superscan pattern or 
flare.
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Introduction
Nasopharyngeal  carcinoma  (NPC)  is  a  unique  malignant 
head and neck cancer with a specific behavior. It is rarely 
reported in the West but occurs at high frequency in South-
ern China, Hong Kong, Taiwan, Singapore, and Malaysia 
[1]. Radiotherapy has long been the standard treatment for 
patients with NPC because of its anatomic location and rela-
tive radiosensitivity. However, a high rate of distant failure 
is observed in patients with advanced NPC. NPC tends to 
metastasize to bone, lung, and liver [2]. Bone imaging using 
technetium-99m methylene diphosphonate (Tc-99m MDP) is 
one of the most frequently used nuclear imaging techniques 
to examine bone lesions [3]. However, diffuse metastasis, 
commonly seen in prostate cancer or breast cancer, are inde-
terminate on images showing superscan and flare phenom-
ena [4]. We reported a case of NPC manifesting superscan 
and flare phenomena on bone images.
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Case Report
A  26-year-old  man  was  diagnosed  with  malignant  NPC, 
which, after treatment, metastasized to bone. At the begin-
ning, he received full cycles of chemotherapy and radio-
therapy. At his regular follow up, back pain was noted after 
definitive treatment for 3 months. So we further investigated 
the progression of his disease by bone scanning. The bone 
scan revealed diffuse increased tracer uptake throughout the 
skeleton (Fig. 1). Because diffuse metastases were highly 
suspected and superscan pattern was revealed, we also ar-
ranged MRI of the spine to confirm the presence of bone 
lesions. Diffuse bony metastases were detected. With dis-
ease  progression,  back  pain  was  exacerbated  and  poorly 
controlled by pain killer medications. Localized radiation 
treatment (300 cGy in 10 fractions) to vertebrae T5, T6, T10, 
and the lower portion of T9, and 3 months after radiotherapy, 
a bone scan to detect the effects, were arranged. However, 
increased diffuse activity indicating diffuse metastases was 
still present (Fig. 2). Examination by 18-fluoro-2-deoxyglu-
cose  positron  emission  tomography  (FDG-PET)  to  deter-
mine the extent of metastatic spread demonstrated multiple 
bony metastatic lesions and enhanced uptake in the skull, 
entire spine, rib cage, pelvic bones, and humeral and femoral 
shafts. Additionally, the PET scan also revealed “cold” le-
sions in areas which had received radiotherapy (Fig. 3).
Discussion
  
Bone scan is a very sensitive method to screen for bone 
abnormalities,  especially  in  cancer  patients.  About  75% 
of patients with malignancy and pain have abnormal bone 
scintigraphic findings [5]. A super scan pattern is character-
ized by a strikingly high bone-to-soft-tissue ratio on skeletal 
scintigraphy. When the bone is hyper-metabolic, the absorp-
tion of isotope by the bone relative to soft tissue and kid-
neys will become greater, and signal from the kidneys will 
consequently be lost. The super scan pattern can be seen in 
a variety of malignant diseases, including breast, lung, and 
prostate cancers [6]. Figure 1 shows the super scan pattern in 
a patient with NPC.  
To evaluate the effect of the treatment, we arranged an-
other bone scan to monitor the bone lesions after radiothera-
py. Interestingly, a flare phenomenon became apparent with-
in short time after radiotherapy. A flare response on Tc-99m 
bone scan indicates progression of bone metastasis despite 
the effectiveness of treatment. Inflammation might increase 
blood flow or the healing reaction might increase bone turn-
over [7, 8]. However, the question remains of why a flare 
reaction is not seen more often. Pollen et al. reported flare 
reaction in 6% of prostate cancer patients 3 months after ini-
tiation of treatment [4]. In our case, a PET scan was arranged 
to make a differential diagnosis. The PET scan revealed that 
the lesions in areas which had received radiotherapy were 
“cold” (Fig. 3). But the Tc-99m MDP bone scan showed a 
uniform symmetrical increase in bone uptake of tracer and 
diminished to absent renal uptake of tracer. Moreover, those 
areas of the spine that received radiotherapy showed a flare 
response (Fig. 2). It seems that the flare reaction briefly af-
fects the bone scan by reducing its capacity to reveal bone 
lesions that had received radiotherapy. 
Thus, the results of bone scans can sometimes be ob-
scured by phenomena such as super scan pattern and flare 
reaction. PET scan can reveal the real bone lesions.
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Figure 3. PET scan image reveals “cold” lesions in areas which received radiotherapy.
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